One of the metrics we track most closely at Ulleo is student completion - because it's one of the clearest signals that what we're building is actually working. Our direct enrolment completion rate is now 69% — compared to an industry benchmark of approximately 46% for domestic fee-for-service VET programs (NCVER, 2024). * That's more than 50% above the closest available reference point. This result doesn't happen by accident. It comes down to the systems we've built around onboarding, mentor support, and ongoing student engagement - and the team that runs them. As we scale, maintaining strong completion rates remains a core focus. Students finishing what they start is the foundation everything else is built on.

🌊 Want to talk directly with the founder changing how we think about ocean pests? Join us for a live Investor Q&A with Henry Cole, Founder & CEO of ROPA™ (Regenerative Ocean Products) — hosted on Birchal. 📅 7 April 2026 🕛 12:00 PM AEDT Henry will be walking through how ROPA is transforming marine pest species into powerful functional bioactive ingredients — and what that means for investors. This is your chance to ask Henry directly about: → The science behind the bioactives → Commercial opportunities → How you can be part of the journey Don't miss it. Register now on Birchal. 👇 #ROPA #Birchal #Investing #BlueEconomy #MarineInnovation #Biotech #RegenerativeOcean

Rush has officially launched 'The Rush Lens'. The Rush Lens is where we cut through market noise and focus on signal. Each piece is a short, sharp read — paired with a simple visual — designed to make what’s happening across markets, macro, and metals clear and usable. No predictions. No hype. Just what matters, and why. We hope you enjoy our first piece. Follow us on LinkedIn if you find this useful so you don't miss the next one. https://www.linkedin.com/posts/rushgold_goldmarket-goldprice-macroinsights-activity-7441967036605435904-NpT0?utm_source=share&utm_medium=member_desktop&rcm=ACoAAAC3fcQBFMI07g2xr8yP5Hi6pNfUOp_HKU0

Amazing to get over $500k invested and also some amazing coverage on News.com. The Earthletica word is spreading and we have great new partners in our business.

https://greenmagazine.com.au/ropas-marine-mission/

We reached out minimum in 48 hours! This is me (post gym) looking at all our new investment partners coming in. So much joy and appreciation for everyone who is joining us on this journey.

Good morning Pulse Tile community, One last note from me before the campaign ends. Thankyou to each and every one of you who have shown support, whether it be via investment, liking and sharing our socials or calling up with a testimony or to share a story. I am so proud of our team and what we've been able to achieve over these last few weeks, including real commercial traction with various stakeholders, team expansion and technical progress. I am also very thankful to Kirstin, Dulce and the team at Birchal for their incredible support throughout the process. With a few hours left, I thought I'd add a little flashback for you to enjoy...thanks Europe! Take care and stay safe out there. Elleesha

This was beyond our wildest imagination! We got to speak to so many of you during this phase and we're blown away by your support and belief in what we're doing. Offer is now open and we look forward to continuing are talks with our newest investors!

$300,000 raised - and we’re not slowing down. We’re incredibly proud to share that Pulse Tile™ has now surpassed the $300K milestone. Thank you to every investor who has backed the mission so far. While the raise has been live, we’ve continued to build real momentum behind the scenes: - We’ve onboarded an additional engineer with deep experience in MedTech sensor development, having recently supported Headsafe through to commercialisation - We’ve progressed a meaningful collaboration with a state ambulance service, who are preparing to provide a formal letter of endorsement - and have also indicated interest in including Pulse Tile™ in clinical trials this year - We’ve gathered valuable data from our large animal study at the Baker Institute, helping inform the design of our first-in-human clinical trials - We’ve become eligible for the TTRA medical device grant, supporting future development and commercialisation - We’ve conducted early health economics analysis, demonstrating the potential for Pulse Tile™ to reduce unnecessary callouts and deliver cost savings for ambulance services and first responder organisations This is exactly the kind of progress your investment helps make possible. With just 2 days remaining, we’re focused on finishing strong and continuing to build momentum into the next phase. If you’ve been considering investing, now is the time. Always consider the general CSF risk warning and offer document before investing.

Aquafab entered the investment phase of our CSF raise. We are excited and proud that over 100 people have choosen to join us on this next exciting stage of our journey. Aquafab reached our minimim target within 18 hours of going live. We look forward now to reaching our goal. If you have any questions please feel free to reach out. Cheers Danny and Rebecca dannykane@aquafab.au